Vascular Device Functionalized Surface Charge Density

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Vascular devices, such as stents, face complications like thrombus formation and restenosis due to surface impurities and protein adsorption, which can lead to adverse reactions in the body, and existing solutions are costly and difficult to manufacture with stable surface characteristics.

Innovation Solution

A vascular device with a functionalized surface featuring double or more charged ions, which are exposed to bodily fluids, reducing thrombogenicity and improving biocompatibility, and a soluble surface sealing to maintain the surface characteristics during handling and insertion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the vascular device surface is provided with surface coatings or adapted surface structures to reduce thrombus formation and improve biocompatibility, then the biological acceptance and healing phase are improved, but the manufacturing cost increases and the surface becomes difficult to clean during handling and storage

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by modifying the surface charge density of the vascular device surface. The surface is engineered to exhibit a positive surface charge density in the range of 0.03 to 0.05 N/m, which is a specific parameter change from conventional neutral or negatively charged surfaces. This parameter modification reduces fibrinogen adhesion and improves biocompatibility without requiring complex coatings or microstructures, thereby avoiding increased manufacturing costs and cleaning difficulties

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If the vascular device surface is provided with surface coatings or adapted surface structures to reduce thrombus formation, then the inflammatory response is reduced, but the surface becomes difficult to clean during handling, storage and implantation

Engineering Contradiction:
Improveinflammatory responseVSAvoidease of cleaning
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The patent modifies the surface charge density parameter to a specific positive range (0.03 to 0.05 N/m) that reduces inflammatory response and fibrinogen adhesion. This parameter-based approach maintains a relatively simple surface topology compared to complex coatings or microstructures, thereby preserving ease of cleaning during handling, storage, and implantation procedures

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the vascular device surface is modified to reduce protein adsorption and improve healing phase, then the biological acceptance is improved, but the manufacturing process becomes more complex and costly

Engineering Contradiction:
Improvehealing phaseVSAvoidsurface treatment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent achieves improved healing phase outcomes by changing the surface charge density parameter to a specific positive range (0.03 to 0.05 N/m). This single parameter modification approach avoids the need for complex multi-layer coatings, microstructures, or sophisticated surface treatments, thereby reducing device complexity and manufacturing costs while maintaining improved biological acceptance and healing characteristics

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The vascular device effectively reduces thrombus formation and improves biocompatibility, allowing for easier manufacturing and handling while maintaining antithrombotic properties over its lifecycle.

Implementation Method 1

the surface of the vascular device is provided with double or more charged ions such that the ions are exposed to a bodily fluid when the vascular device is inserted in the body lumen

Methodology Applied
Scientific EffectElectrostatic repulsion: Ion Repulsion/Attraction

Data Source

PatentUS20210338897A1Vascular device and method for manufacturing a vascular device
Publication Date: 2021.11.04 QVANTEQ AG
  • US20210338897A1 patent drawing
  • US20210338897A1 patent drawing

AI summary

A vascular device for insertion in a body lumen, wherein the device includes a surface including at least a portion that is a functionalized surface provided with double or more charged ions such that the ions are exposed to a bodily fluid when the vascular device is inserted in the body lumen. The vascular device allows for reducing complications in its use and, particularly, for improving a desired healing in the body and preventing restenosis. At the same time, it allows for being manufactured at comparably low effort and for a convenient handling.